Tradestie Institutional Equity Comparison Engine
AMS vs DXR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
DXR Overall Edge
DXR Captures Institutional Edge (2โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Daxor Corporation Common Stock (DXR) driven by superior Growth & Margin, Momentum & Technical while AMS counters with relative strength in Valuation. Fundamentally, AMS trades at 44.6x Forward P/E with -7.4% operating margin (+19.2% YoY revenue) versus DXR at 64.5x Forward P/E and -5894.3% operating margin (+25.5% YoY). In options structure, AMS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against DXR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
AMS
AMS 44.6x vs DXR 64.5x Fwd P/E
Growth & Margin Winner
DXR
Op Margin -7.4% vs -5894.3% ยท YoY +19.2% vs +25.5%
Momentum & Technical Winner
DXR
1Y -52.2% vs -38.3% ยท 52W Pos 6% vs 2%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AMS
NYSE American
American Shared Hospital Services
Services-Medical Laboratories
$1.07
-0.93% 1D
Market Cap
$7.2M
1M Return
-16.41%
1Y Return
-52.23%
Forward P/E
44.6x
Unified AI Score
33.8 / 100
SELL
Tech 24.0
Fund 38.0
Flow 50.0
Mom 30.0
DXR
NASDAQ
Daxor Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$8.36
-1.47% 1D
Market Cap
$49.5M
1M Return
-16.87%
1Y Return
-38.29%
Forward P/E
64.5x
Unified AI Score
52.2 / 100
HOLD
Tech 52.0
Fund 59.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AMS -52.23%
DXR -38.29%
Spread: +18.96 pp (DXR Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AMS TTM Op. Margin: -7.4%
DXR TTM Op. Margin: -5894.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMS vs DXR. Trailing 12-month operating profitability (AMS -7.4% vs DXR -5894.3%) and valuation multiples (AMS 44.6x vs DXR 64.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AMS | DXR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $7.2M | $49.5M | Larger Scale | DXR |
| Trailing P/E Ratio Valuation | 44.6x | 7.7x | Lower Multiple | DXR |
| Forward P/E Ratio Valuation | 44.6x | 64.5x | Lower Multiple | AMS |
| Revenue Growth (YoY) Growth | +19.2% | +25.5% | Higher Growth | DXR |
| Operating Margin (TTM) Profitability | -7.4% | -5894.3% | Higher Margin | AMS |
| Net Profit Margin Profitability | -5.8% | 19861.4% | Higher Margin | DXR |
| Return on Equity (ROE) Capital Efficiency | -12.1% | 14.2% | Higher ROE | DXR |
| 52-Week Range Position Momentum | 6% ($1โ$2) | 2% ($8โ$15) | Stronger Trend | AMS |
| Beta / 30D Volatility Risk Regime | 0.18ฮฒ ยท 46% Vol | 0.28ฮฒ ยท 32% Vol | Lower Realized Risk | DXR |
| Unified Institutional Score Composite Signal | 33.8 / 100 (SELL) | 52.2 / 100 (HOLD) | Higher Composite | DXR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AMS vs DXR Buy Guide
AMS
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
DXR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AMS nor DXR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.